Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
WITHDRAWN
NCT04177303
PHASE3

Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment

Sponsor: Hellenic Institute for the Study of Sepsis

View on ClinicalTrials.gov

Summary

Investigators aim is to conduct an RCT to study the effect of adjunct metformin treatment to insulin monotherapy in patients with type 1 diabetes, targeting the intestinal incretin secretion. The patients will be randomly allocated to metformin or placebo treatment for 4 months

Official title: Gut-derived Incretin Hormones in the Pathophysiology of Type 1 Diabetes Mellitus; Effect of Metformin Treatment

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

0

Start Date

2019-11-29

Completion Date

2024-12-31

Last Updated

2026-11-03

Healthy Volunteers

No

Interventions

DRUG

Metformin

Participants will be randomized to metformin 2000 mg

DRUG

Placebo

Participants will be randomized to placebo